2.85
前日終値:
$2.68
開ける:
$2.66
24時間の取引高:
661.90K
Relative Volume:
1.19
時価総額:
$228.50M
収益:
当期純損益:
$-124.74M
株価収益率:
-0.0054
EPS:
-527.5896
ネットキャッシュフロー:
$-149.71M
1週間 パフォーマンス:
+1.06%
1か月 パフォーマンス:
-31.49%
6か月 パフォーマンス:
-68.23%
1年 パフォーマンス:
-73.78%
Robostrategy Inc Stock (BBOT) Company Profile
名前
Robostrategy Inc
セクター
電話
857 702 0377
住所
256 E. GRAND AVENUE, SUITE 104, SOUTH SAN FRANCISCO
Compare BBOT vs VRTX, REGN, MRNA, ARGX, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
BBOT
Robostrategy Inc
|
2.85 | 228.50M | 0 | -124.74M | -149.71M | -527.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
535.17 | 135.64B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
819.09 | 84.33B | 14.92B | 4.42B | 3.79B | 41.04 |
|
MRNA
Moderna Inc
|
202.63 | 80.90B | 2.23B | -3.19B | -1.60B | -8.1462 |
|
ARGX
Argen X Se Adr
|
875.76 | 55.07B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
382.27 | 43.24B | 5.76B | 514.49M | 1.10B | 4.4813 |
Robostrategy Inc Stock (BBOT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-07-08 | 開始されました | JP Morgan | Overweight |
| 2026-06-22 | 再開されました | Oppenheimer | Outperform |
| 2026-05-11 | 開始されました | Canaccord Genuity | Buy |
| 2026-02-11 | 開始されました | Stifel | Buy |
| 2026-01-09 | 開始されました | Raymond James | Outperform |
| 2025-12-05 | 開始されました | Morgan Stanley | Overweight |
| 2025-09-17 | 開始されました | Leerink Partners | Outperform |
| 2025-09-15 | 開始されました | H.C. Wainwright | Buy |
| 2025-08-15 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Robostrategy Inc (BBOT) 最新ニュース
BridgeBio Oncology: The KRAS Opportunity Hidden In The Selloff (NASDAQ:BBOT) - Seeking Alpha
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Form 4 BridgeBio Oncology Therapeutics Inc For: 12 October By Investing.com - Investing.com Nigeria
Form 4 BridgeBio Oncology Therapeutics Inc For: 12 October By Investing.com - Investing.com India
Form 4 BridgeBio Oncology Therapeutics Inc For: 12 October By Investing.com - Investing.com Canada
Form 4 BridgeBio Oncology Therapeutics Inc For: 12 October By Investing.com - Investing.com UK
BridgeBio Oncology Therapeutics, Inc (NASDAQ:BBOT) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
BridgeBio Oncology Therapeutics (Nasdaq:BBOT)Stock Analysis - Simply Wall Street
BridgeBio Oncology COO Idan Elmelech Reports RSU Tax Withholding via Share Disposal - Kalkine Media
343 shares withheld for taxes leave BridgeBio Oncology (BBOT) COO with 14,152 shares. - Stock Titan
BridgeBio Oncology Therapeutics, Inc (NASDAQ:BBOT) Short Interest Update - MarketBeat
Perspective Therapeutics (NYSEAM:CATX)Stock Analysis - Simply Wall Street
BridgeBio Oncology (BBOT) grants 43,700 options to principal accounting officer - Stock Titan
BridgeBio Oncology Therapeutics, Inc (NASDAQ:BBOT) Receives Average Rating of "Moderate Buy" from Brokerages - marketbeat.com
Price to earnings forward of RoboStrategy, Inc. – LSX:A41MQ2 - TradingView
Opaleye Management Inc. Purchases 646,718 Shares of BridgeBio Oncology Therapeutics, Inc $BBOT - marketbeat.com
BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Sets New 1-Year LowTime to Sell? - marketbeat.com
RoboStrategy Company Profile & Introduction - Moomoo
BridgeBio Oncology Therapeutics Targets Key Data Milestones for 2026 and 2027 with Focus on BBO-8520 Combo (NASDAQ: BBOT) - Kalkine Media
BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Shares Down 9.4%Time to Sell? - marketbeat.com
Stifel cuts BridgeBio Oncology price target on pipeline shift - Investing.com
RoboStrategy CEO: Tesla's robotics edge is manufacturing, not AI - scanx.trade
BOT Should I Buy - Intellectia AI
Cash flow from investing activities of RoboStrategy, Inc. – MUN:S0I - TradingView
Enterprise value to revenue forward of RoboStrategy, Inc. – MUN:S0I - TradingView
RoboStrategy Reports August 31, 2026 Net Asset Value Per Share of $11.35 - Quiver Quantitative
RoboStrategy, Inc. Updates Net Asset Value as of August 31, 2026 - The Manila Times
RoboStrategy, Inc. Updates Net Asset Value as of August 31, 2026 - marketscreener.com
Tesla (NASDAQ: TSLA) Robotics Edge Lies In Manufacturing, Not AI, RoboStrategy CEO Argues - foreignpolicyjournal.com
Anthropic's Growth Is Reshaping Robotics ValuationsRoboStrategy (NASDAQ:BOT) - Benzinga
How to Value a Robotics Company Beyond RevenueRoboStrategy (NASDAQ:BOT) - Benzinga
EXCLUSIVE: Tesla's Biggest Robotics Advantage Isn't AI, RoboStrategy CEO Says - Yahoo Finance
Tesla's Optimus Trails Figure AI in Production Race, RoboStrategy CEO Says - finance.biggo.com
EXCLUSIVE: Tesla Isn't Leading Humanoid Robotics—Figure AI Is, RoboStrategy CEO Says - Benzinga
RoboStrategy, Inc. Releases First Shareholder Letter - Barchart.com
RoboStrategy Shares Drop After Release of First Shareholder Letter - marketscreener.com
BridgeBio (BBOT) Shares: Finishes 0.66% Up at $9.14 on the Day; Level Watch: the Price Remains Bounded by the Supplied Support and Resistance in the Current UpdateCommon Gap - dars.gov.et
RoboStrategy (Backpack Securities) Team - CryptoRank
Enterprise value to EBIT forward of RoboStrategy, Inc. – LSX:A41MQ2 - TradingView
RoboStrategy tokenized stockxStock Price: Live BOTX/USD Rate, Market Cap & BOTX Price Chart - CoinCodex
BOT/BBD: Convert RoboStrategy, Inc. (BOT) to Barbadian Dollar (BBD) - OKX
Buy RoboStrategy, Inc. (XBOT) with credit card | How to Buy RoboStrategy, Inc. - OKX
RoboStrategy, Inc. Price Today | xBOT Live Price, Chart & Market Cap - okx.com
RoboStrategy(BOT) Stock Options Chain | Quotes & News - Moomoo
xBOT to BND | Convert RoboStrategy, Inc. to Brunei Dollar - OKX
BWP to xBOT | Convert Botswanan Pula to RoboStrategy, Inc. - OKX
RoboStrategy, Inc. Price Today | xBOT Live Price, Chart & Market Cap - OKX
MNT to xBOT | Convert Mongolian Tugrik to RoboStrategy, Inc. - OKX
RoboStrategy (Backpack Securities) - CryptoRank
Historical Data for RoboStrategy (Backpack Securities) in USD - CryptoRank
Robostrategy Inc (BBOT) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):